& Johnson Johnson's Net Worth

$4.29 Billion

Who is & Johnson Johnson?

& Johnson Johnson has an estimated net worth of $4.29 Billion. This is based on reported shares across multiple companies, which include CVRx, Inc., Fusion Pharmaceuticals Inc., Provention Bio, Inc., Inspire Medical Systems, Inc., ACHILLION PHARMACEUTICALS INC, Minerva Neurosciences, Inc., Protagonist Therapeutics, Inc, AQUINOX PHARMACEUTICALS, INC, NEVRO CORP, Aldeyra Therapeutics, Inc., GENOCEA BIOSCIENCES, INC., TENGION INC, BARRIER THERAPEUTICS INC, IMMUNICON CORP, CRITICAL THERAPEUTICS INC, UNIVERSAL BIOSENSORS INC, EXEGENICS INC, ANIMAS CORP, CLOSURE MEDICAL CORP, Kenvue Inc., and MeiraGTx Holdings plc.

SEC CIK

& Johnson Johnson's CIK is 0000200406

Past Insider Trading and Trends

2014 was & Johnson Johnson's most active year for acquiring shares with 9 total transactions. & Johnson Johnson's most active month to acquire stocks was the month of May. 2014 was & Johnson Johnson's most active year for disposing of shares, totalling 38 transactions. & Johnson Johnson's most active month to dispose stocks was the month of March. 2020 saw & Johnson Johnson paying a total of $12,325,000.00 for 3,759,634 shares, this is the most they've acquired in one year. In 2017 & Johnson Johnson cashed out on 22,259,602 shares for a total of $50,510,590.73, their largest year based on trade value.